This study aimed to investigate the metabolic alterations that occur during PAD4 inhibitor (YW3-56)-induced differentiation of NB4 acute promyelocytic leukemia cells, and to examine their potential associations with key signaling pathways such as AKT/mTOR. Here, AKT1 is linked to acute promyelocytic leukemia.